Skip to content
★ Sign in to follow
RA

Robert Alan Schueren

Executive
Former Chief Operating Officer
Natera, Inc.WaferGen Bio-systems, Inc.
Total declarations
125
Companies
2
▲ Purchases (0 ops.)
—
▼ Sales (58 ops.)
€17.4M

Latest filing published 31 Jan 2023 for Natera, Inc..

Filing timeline

BuySale
Robert Alan Schueren

Insider track record

Disclosed buys
0
Disclosed sells
58
Signal history

Robert Alan Schueren: trading record in brief

Robert Alan Schueren (senior executive) discloses dealings in 2 companies, chiefly Natera, Inc. and WaferGen Bio-systems, Inc. Between 29 May 2014 and 27 January 2023, the trades on record add up to 125 filings.

On the market, this insider has only sold: 58 sales, €17.4M in total. Outside the open market, there are 6 share grants and 56 option exercises. Since January 2023: no purchases and 3 sales on the market.

Most recently, on 31 January 2023, the filings show a share grant in Natera, Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Robert Alan Schueren

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations124 total

25 of 124 declarations